Prevalence of Sarcopenia and Relevance of Body Composition, Physiological Function, Fatigue, and Health-related Quality of Life in Patients Before Allogeneic Hematopoietic Stem Cell Transplantation
Overview
Oncology
Authors
Affiliations
Purpose: Cachexia in patients with hematological malignancies is often related to sarcopenia. We believe that allogeneic hematopoietic stem cell transplant (allo-HSCT) patients often exhibit sarcopenia prior to transplantation. Here, we aimed to investigate the prevalence of sarcopenia and its relationship with body composition, physiological function, nutrition, fatigue, and health-related quality of life (QOL) in patients before allo-HSCT. We further investigated the confounding factors associated with sarcopenia.
Methods: We included 164 patients with allo-HSCT in this study. Body composition, handgrip, knee extensor strength, and 6-min walk test were evaluated. Furthermore, fatigue, nutritional status, and health-related QOL were also evaluated.
Results: Eighty-three patients (50.6 %) enrolled in our study had sarcopenia prior to allo-HSCT. Patients with sarcopenia experienced decreased muscular strength and increased fatigue compared with patients without sarcopenia (p < 0.05). Patients with sarcopenia showed significantly lower scores in physical functioning, bodily pain, and vitality in health-related QOL than those without sarcopenia. Multivariate regression analysis revealed that only gender and body mass index were significantly related to sarcopenia (gender, odds ratio, 3.09; body mass index, odds ratio, 0.70; p < 0.01).
Conclusions: Sarcopenia is common in patients before allo-HSCT and related to low muscle strength, fatigue, and health-related QOL. Male patients may be more susceptible to sarcopenia than female patients before allo-HSCT. Further study of rehabilitation with gender insight is warranted for patients receiving allo-HSCT.
Limbach M, Kuehl R, Koeppel M, Dreger P, Luft T, Bohus M Support Care Cancer. 2025; 33(2):89.
PMID: 39794666 PMC: 11723852. DOI: 10.1007/s00520-024-09140-8.
Head and Neck Cancer and Sarcopenia: An Integrative Clinical and Functional Review.
Endo K, Ichinose M, Kobayashi E, Ueno T, Hirai N, Nakanishi Y Cancers (Basel). 2024; 16(20).
PMID: 39456555 PMC: 11506384. DOI: 10.3390/cancers16203460.
van Lieshout R, Tick L, Beckers E, Biesbroek W, Dieleman J, Dijkstra M Eur J Clin Nutr. 2024; 78(12):1082-1094.
PMID: 39127840 DOI: 10.1038/s41430-024-01488-8.
Terao Y, Nakayama Y, Abo M, Otobe Y, Suzuki M, Kojima I Support Care Cancer. 2024; 32(8):512.
PMID: 39001992 DOI: 10.1007/s00520-024-08729-3.
Leite V, Oza S, Parke S, Barksdale T, Herbert A, Bansal V Rehabil Oncol. 2024; 42(2):91-99.
PMID: 38912164 PMC: 11192508. DOI: 10.1097/01.REO.0000000000000363.